
www.Usenet.com
| <-- __Chronological__ --> | <-- __Thread__ --> |
I was wondering if any clinicians (or anyone with first-hand experience) could offer any opinions or information as to the degree of use some of the current high-tech catheter systems are getting. Specifically: 1) Endocardial Solutions (EnSite 3000) 2) Biosense Webster / J&J (CARTO XP, NAVI-STAR catheter) 3) Medtronic (LocaLisa) 4) Boston Scientific (RPM Realtime Position Management System) Generally, these hi-tech catheter systems can produce electro-anatomical 3-D maps and images used to position the catheter for diagnostic or theraputic action with reduced (or no?) reliance on flouroscopy. They claim to be able to reduce procedure time and give better outcomes for various conditions (atrial fibrillation and flutter, etc). I'm wondering if those systems are viewed by cardiologists as either (a) still experimental, (b) yet to show clinical superiority or better cost / benefit, or (c) well on their way to becoming standard hospital equipment. Basically, is the cardiology field adopting this technology or is it as much of a curiosity as, say, robotic surgery? ???
| <-- __Chronological__ --> | <-- __Thread__ --> |